glp-1 receptor agonists effects on cardiovascular risk reduction

glp-1 receptor agonists effects on cardiovascular risk reduction Glucagon-like peptide-1 agonist in myocardial infarction and atherosclerotic disease reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety | Cardiovascular Diabetology Heart transplantation in the GLP-1

Name: glp-1 receptor agonists effects on cardiovascular risk reduction Glucagon-like peptide-1 agonist in myocardial infarction and atherosclerotic disease reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety | Cardiovascular Diabetology Heart transplantation in the GLP-1
Brand: actil.am
SKU: 98692101811
Price: 26.27 USD
Availability: InStock
Rating: 4.7974000000000006 (7 reviews)

SKU: 98692101811

4.8

USD26.27 USD53.27

Pay in 4 interest-free payments of $6.57 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 24 - Aug 29

Description

Besides improving glucose control, reducing body weight, and lowering arterial blood pressure (surrogate endpoints), the breakthroughs were the demonstration of a significant reduction in cardiovascular and renal events in patients with type 2 diabetes at high risk